doi: 10.1097/00126334-200106010-00018.
Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio: call for consensus
- PMID: 11404545
- DOI: 10.1097/00126334-200106010-00018
Item in Clipboard
Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio: call for consensus
J Acquir Immune Defic Syndr.
.
No abstract available
Similar articles
-
Reliability of Cmin: inhibitory concentration ratios.J Infect Dis. 2001 Mar 15;183(6):992-4. doi: 10.1086/319265. J Infect Dis. 2001. PMID: 11237820 No abstract available.
-
Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study).AIDS. 2002 Jul 5;16(10):1331-40. doi: 10.1097/00002030-200207050-00004. AIDS. 2002. PMID: 12131209 Clinical Trial.
-
Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and below.Antivir Ther. 2007;12(4):453-8. Antivir Ther. 2007. PMID: 17668553
-
The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.J HIV Ther. 2008 Mar;13(1):9-18. J HIV Ther. 2008. PMID: 18953268 Review. No abstract available.
-
Clinical pharmacology and pharmacokinetics of amprenavir.Ann Pharmacother. 2002 Jan;36(1):102-18. doi: 10.1345/aph.10423. Ann Pharmacother. 2002. PMID: 11816239 Review.
Cited by
-
Estimation of serum-free 50-percent inhibitory concentrations for human immunodeficiency virus protease inhibitors lopinavir and ritonavir.Antimicrob Agents Chemother. 2004 Aug;48(8):2911-7. doi: 10.1128/AAC.48.8.2911-2917.2004. Antimicrob Agents Chemother. 2004. PMID: 15273100 Free PMC article.
-
The liver partition coefficient-corrected inhibitory quotient and the pharmacokinetic-pharmacodynamic relationship of directly acting anti-hepatitis C virus agents in humans.Antimicrob Agents Chemother. 2012 Oct;56(10):5381-6. doi: 10.1128/AAC.01028-12. Epub 2012 Aug 6. Antimicrob Agents Chemother. 2012. PMID: 22869578 Free PMC article.
-
Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients.Antimicrob Agents Chemother. 2004 Jun;48(6):2091-6. doi: 10.1128/AAC.48.6.2091-2096.2004. Antimicrob Agents Chemother. 2004. PMID: 15155205 Free PMC article. Clinical Trial.
-
Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C.Antimicrob Agents Chemother. 2013 Oct;57(10):4727-35. doi: 10.1128/AAC.00565-13. Epub 2013 Jul 15. Antimicrob Agents Chemother. 2013. PMID: 23856779 Free PMC article. Clinical Trial.
-
Once-daily administration of antiretrovirals: pharmacokinetics of emerging therapies.Clin Pharmacokinet. 2003;42(14):1179-91. doi: 10.2165/00003088-200342140-00001. Clin Pharmacokinet. 2003. PMID: 14606928 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
